Jones Financial Companies’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.18K Sell
87
-8
-8% -$292 ﹤0.01% 3302
2025
Q1
$3.59K Sell
95
-42
-31% -$1.59K ﹤0.01% 3069
2024
Q4
$5.76K Buy
137
+109
+389% +$4.59K ﹤0.01% 2712
2024
Q3
$1.52K Sell
28
-10
-26% -$544 ﹤0.01% 2733
2024
Q2
$1.56K Buy
+38
New +$1.56K ﹤0.01% 2210